The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid
Authors:
- André M. MuellerAMAndré M. Mueller
- Xiomara PedréXPXiomara Pedré
- Andreas SteinbrecherASAndreas Steinbrecher
- 1 April 2009
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 209 (1-2) , 57-64
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Induction and effector functions of TH17 cellsNature, 2008
- TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune diseaseJournal of Experimental Medicine, 2008
- Decoy Receptor 3 Ameliorates an Autoimmune Crescentic Glomerulonephritis Model in MiceJournal of the American Society of Nephrology, 2007
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implicationJournal of Leukocyte Biology, 2003
- Signalling pathways of the TNF superfamily: a double-edged swordNature Reviews Immunology, 2003
- Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathologySeminars in Immunology, 2003
- Targeted Disruption of LIGHT Causes Defects in Costimulatory T Cell Activation and Reveals Cooperation with Lymphotoxin β in Mesenteric Lymph Node GenesisJournal of Experimental Medicine, 2002
- TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell CostimulatorImmunity, 2002